Illumina

Senior Clinical Informatics Sales Specialist, West

Texas, United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Genomics, Clinical DiagnosticsIndustries

Requirements

Candidates must possess strong genomics, healthcare, and informatics technical knowledge and expertise. Experience in selling Next Generation Sequencing and Genomic data analysis pipelines, applications, and products is essential. The role requires the ability to engage effectively with C-level executives, Laboratory Directors, Healthcare practitioners, IT leaders, and data analysts. Expertise in data visualization, data science including AI and Machine Learning, cloud-based workflows, LIMS, and NGS data analysis in a clinical environment is necessary. Experience with oncology research and testing data analysis is also required.

Responsibilities

The Senior Clinical Informatics Sales Specialist will identify and close informatics opportunities by selling Illumina's clinical software products and associated services. Responsibilities include providing technical guidance and subject matter expertise during the sales cycle, consulting with customers on informatics requirements, and performing proof-of-concept analyses. The specialist will partner with third-party providers to offer end-to-end solutions, collaborate with sales teams to ensure customer success in clinical genomic data analysis, and develop/conduct informatics presentations and seminars. They will also provide Voice of Customer feedback to development and marketing teams, train the broader sales organization on clinical informatics, and remove informatics barriers to unlock sample volume and drive sales growth.

Skills

Genomics
Healthcare Informatics
Next Generation Sequencing (NGS)
Genomic Data Analysis
Clinical Research
Clinical Testing
Sales
Cloud-based Enterprise Platforms
Data Analysis
Data Interpretation

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI